These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 26853260
1. A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders. Perrone M, Moon BS, Park HS, Laquintana V, Jung JH, Cutrignelli A, Lopedota A, Franco M, Kim SE, Lee BC, Denora N. Sci Rep; 2016 Feb 08; 6():20422. PubMed ID: 26853260 [Abstract] [Full Text] [Related]
2. [18F]CB251 PET/MR imaging probe targeting translocator protein (TSPO) independent of its Polymorphism in a Neuroinflammation Model. Kim K, Kim H, Bae SH, Lee SY, Kim YH, Na J, Lee CH, Lee MS, Ko GB, Kim KY, Lee SH, Song IH, Cheon GJ, Kang KW, Kim SE, Chung JK, Kim EE, Paek SH, Lee JS, Lee BC, Youn H. Theranostics; 2020 Feb 08; 10(20):9315-9331. PubMed ID: 32802194 [Abstract] [Full Text] [Related]
3. Preclinical comparison study between [18F]fluoromethyl-PBR28 and its deuterated analog in a rat model of neuroinflammation. Moon BS, Jung JH, Park HS, Contino M, Denora N, Lee BC, Kim SE. Bioorg Med Chem Lett; 2018 Sep 15; 28(17):2925-2929. PubMed ID: 30122224 [Abstract] [Full Text] [Related]
4. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images. Damont A, Médran-Navarrete V, Cacheux F, Kuhnast B, Pottier G, Bernards N, Marguet F, Puech F, Boisgard R, Dollé F. J Med Chem; 2015 Sep 24; 58(18):7449-64. PubMed ID: 26280386 [Abstract] [Full Text] [Related]
5. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF, Black AM, Clarke A, Durrant C, Gausemel I, Khan I, Mantzilas D, Oulie I, Rogstad A, Trigg W, Jones PA. Nucl Med Biol; 2015 Sep 24; 42(9):711-9. PubMed ID: 26072270 [Abstract] [Full Text] [Related]
6. Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([18F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammation. Tang D, Fujinaga M, Hatori A, Zhang Y, Yamasaki T, Xie L, Mori W, Kumata K, Liu J, Manning HC, Huang G, Zhang MR. Eur J Med Chem; 2018 Apr 25; 150():1-8. PubMed ID: 29505933 [Abstract] [Full Text] [Related]
7. Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism. Lee SH, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH, Kim HW, Kim SB, Park HS, Kim K, Lee SY, Youn H, Lee BC, Kim SE. Eur J Nucl Med Mol Imaging; 2021 Dec 25; 49(1):110-124. PubMed ID: 34783879 [Abstract] [Full Text] [Related]
8. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation. Zheng J, Winkeler A, Peyronneau MA, Dollé F, Boisgard R. Mol Imaging Biol; 2016 Feb 25; 18(1):127-34. PubMed ID: 26194010 [Abstract] [Full Text] [Related]
9. PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa). Hatori A, Yui J, Yamasaki T, Xie L, Kumata K, Fujinaga M, Yoshida Y, Ogawa M, Nengaki N, Kawamura K, Fukumura T, Zhang MR. PLoS One; 2012 Feb 25; 7(9):e45065. PubMed ID: 22984611 [Abstract] [Full Text] [Related]
10. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. Chauveau F, Van Camp N, Dollé F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B. J Nucl Med; 2009 Mar 25; 50(3):468-76. PubMed ID: 19223401 [Abstract] [Full Text] [Related]
11. Characterization of a novel acetamidobenzoxazolone-based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain. Tiwari AK, Yui J, Fujinaga M, Kumata K, Shimoda Y, Yamasaki T, Xie L, Hatori A, Maeda J, Nengaki N, Zhang MR. J Neurochem; 2014 May 25; 129(4):712-20. PubMed ID: 24484439 [Abstract] [Full Text] [Related]
12. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [11 C]PBR28. Frankle WG, Narendran R, Wood AT, Suto F, Himes ML, Kobayashi M, Ohno T, Yamauchi A, Mitsui K, Duffy K, Bruce M. Synapse; 2017 Jul 25; 71(7):. PubMed ID: 28245513 [Abstract] [Full Text] [Related]
13. Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714. Cacheux F, Médran-Navarrete V, Dollé F, Marguet F, Puech F, Damont A. Eur J Med Chem; 2017 Jan 05; 125():346-359. PubMed ID: 27688189 [Abstract] [Full Text] [Related]
14. 18F-labeled ethisterone derivative for progesterone receptor targeted PET imaging of breast cancer. Gao F, Peng C, Zhuang R, Guo Z, Liu H, Huang L, Li H, Xu D, Wen X, Fang J, Zhang X. Nucl Med Biol; 2019 Jan 05; 72-73():62-69. PubMed ID: 31330414 [Abstract] [Full Text] [Related]
15. [18F]FEBMP: Positron Emission Tomography Imaging of TSPO in a Model of Neuroinflammation in Rats, and in vitro Autoradiograms of the Human Brain. Tiwari AK, Ji B, Yui J, Fujinaga M, Yamasaki T, Xie L, Luo R, Shimoda Y, Kumata K, Zhang Y, Hatori A, Maeda J, Higuchi M, Wang F, Zhang MR. Theranostics; 2015 Jan 05; 5(9):961-9. PubMed ID: 26155312 [Abstract] [Full Text] [Related]
16. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker. Kreisl WC, Fujita M, Fujimura Y, Kimura N, Jenko KJ, Kannan P, Hong J, Morse CL, Zoghbi SS, Gladding RL, Jacobson S, Oh U, Pike VW, Innis RB. Neuroimage; 2010 Feb 15; 49(4):2924-32. PubMed ID: 19948230 [Abstract] [Full Text] [Related]
17. Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat. Yanamoto K, Yamasaki T, Kumata K, Yui J, Odawara C, Kawamura K, Hatori A, Inoue O, Yamaguchi M, Suzuki K, Zhang MR. Synapse; 2009 Nov 15; 63(11):961-71. PubMed ID: 19593823 [Abstract] [Full Text] [Related]
18. [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model. Xie L, Yamasaki T, Ichimaru N, Yui J, Kawamura K, Kumata K, Hatori A, Nonomura N, Zhang MR, Li XK, Takahara S. J Neuroimmune Pharmacol; 2012 Mar 15; 7(1):231-42. PubMed ID: 22038158 [Abstract] [Full Text] [Related]
19. Positron-emission tomography imaging of the TSPO with [(18)F]FEPPA in a preclinical breast cancer model. Vasdev N, Green DE, Vines DC, McLarty K, McCormick PN, Moran MD, Houle S, Wilson AA, Reilly RM. Cancer Biother Radiopharm; 2013 Apr 15; 28(3):254-9. PubMed ID: 23350894 [Abstract] [Full Text] [Related]
20. [18F]FEPPA a TSPO Radioligand: Optimized Radiosynthesis and Evaluation as a PET Radiotracer for Brain Inflammation in a Peripheral LPS-Injected Mouse Model. Vignal N, Cisternino S, Rizzo-Padoin N, San C, Hontonnou F, Gelé T, Declèves X, Sarda-Mantel L, Hosten B. Molecules; 2018 Jun 07; 23(6):. PubMed ID: 29875332 [Abstract] [Full Text] [Related] Page: [Next] [New Search]